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Abstract 
 
  This study was done to determine the MICs of  the quinolones  Ciprofloxacin and 
Norfloxacin  for  30 isolates of pathogenic Staphylocoocus aureus by manual E-
test and comparison with disk diffusion test.  .  
The present study demonstrated  differences in susceptibility test to the two 
antibiotics with disk diffusion method and manual E-test method. 
The  isoltes   showed 80%  sensitivity to ciprofloxacin with an MIC range of 0.03-
0.62µgml and 86% to norfloxacin with an MIC range of  0.07-2.5µgml  with 
manual E test . By disc diffusion test they showed  sensitivity of 73.3% for 
ciprofloxacin and 63.3% for norfloxacin. 
 The Etest susceptibility method is  a rapid , simple  and reliable technique  as it 
combines the functions of both dilution and diffusion techniques. 
  The agar disc diffusion method is  also  reliable, rapid, easy and inexpensive. but 
does not combine the two functoin as in Etest. 
 We strongly recommend the use of Etest sensitivity method in diagnostic and 
research labrotaries in sudan and other developing countries 
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INTRODUCTION 
 
    Staphylococcus aureus has been recovered as commensal flora of the skin 
surfaces of the anterior nares, perineum and other sites in 10-15% of healthy 
adults.  The percentage is significantly higher among hospitalized individuals, 
including health care workers.  It should also be evident that health care workers 
can serve as an important source of organisms for the hospitalized patient. 
Staphylococcus aureus has been recovered from a wide range of suppurative and 
non-suppurative infections. And it causes most serious disease and nosocomial 
infections (Kluytmans et al., 1997). Unlike some other types of bacteria, 
staphylococci are generally partly or wholly resistant to antibiotic action; this 
raises serious problems in the treatment and control of staphylococcus infections. 
The rise of drug- resistant virulent strains of S. aureus, particularly Methicillin-
resistantS. aureus (MRSA), has led increasing concern in the medical community. 
It is resistant to a family of antibiotics related to penicillin that includes antibiotics 
called methicillin and oxacillin, and is often resistant to many other antibiotics as 
well. 
    Most isolates of S. aureus are resistant to penicillin, usually due to the 
production of ß-lactamase (penicillinase) specified by plasmids.   
 In the past, the antibiotic methicillin has been the drug of choice for treating 
infections for these organisms.  An increasing percentage (10-50%) of 
staphylococci isolated from nosocomial infections is now resistant to methicillin as 
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well as a large number of other antibiotics.  The first case of methicillin-resistant S. 
aureus (MRSA) was reported in England (Jevons, 1961).   These infections must 
be treated with the drug Vancomycin.  Most have involved S. aureus (MRSA) and 
S. epidermidis (MRSE) although other species have been reported.  Oxacillin disks 
or agar are generally used for the detection of methicillin resistance. 
     Vancomycin has been the cornerstone of therapy for serious methicillin-
resistant Staphylococcus aureus (MRSA) infections since the early 1980s, when 
MRSA emerged as a significant nosocomial pathogen in the United States ( Bayer 
et al. , 1998). However, many clinicians believe that the efficacy of vancomycin 
against MRSA is inferior to that of antistaphylococcal beta-lactams against 
methicillin-susceptible S. aureus (MSSA) infections.  The first case of vancomycin 
intermediate S. aureus (VISA) was reported in Japan in 1996; (Hiramatsu et al., 
1997). New agents that have been approved for treatment of MRSA skin infections 
include linezolid, Quinupristin-dalfopristin, Daptomycin and Lysostaphin.   
 Norfloxacin, ciprofloxacin, and ofloxacin are the most commonly used 
quinolones.  They inhibit type 2 topoisomerase, a DNA gyrase involved in the 
supertwisting of bacterial DNA molecules, replication, and repair. Resistance to 
fluoroquinolones has been found in MSSA and MRSA strains . Both altered gyrase 
and energy-dependent efflux mechanisms account for the development of 
resistance to fluoroquinolones   ( Kaatz et al.,1991). 
     Resistance to antimicrobial agents (AMR) has resulted in morbidity and mortality 
from treatment failures and increased health care costs. Appropriate antimicrobial 
drug use has unquestionable benefit, but physicians and the public frequently use 
these agents inappropriately. Inappropriate use results from physicians providing 
antimicrobial drugs to treat viral infections, using inadequate criteria for diagnosis of 
infections.Widespread antibiotic usage exerts a selective pressure that acts as a 
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driving force in the development of antibiotic resistance. The association between 
increased rates of antimicrobial use and resistance has been documented for 
nosocomial infections as well as for resistant community acquired infections. As 
resistance develops to "first-line" antibiotics, therapy with new, broader spectrum, 
more expensive antibiotics increases, but is followed by development of resistance to 
the new class of drugs.Resistance factors, particularly those carried on mobile 
elements, can spread rapidly within human and animal populations. Multidrug-
resistant pathogens travel not only locally but also globally. The success of treatment 
of infections depends on the use of appropriate antimicrobial agents directed 
against the pathogen. 
     The minimum inhibitory concentration (MIC) has long been the standard for 
antibiotic susceptibility testing. The central concept of a MIC is that it is a 
measurement of the activity of an antibacterial agent against an individual strain of 
an organism. It has become the reference measuring tool for susceptibility testing. . 
The true value of a MIC is as a measuring tool that generates values to which other 
parameters.The origins of  the  MIC can be traced back to the original Fleming 
paper on penicillin (strictly, on cultures of a Penicillium strain) ( Fleming , 1929) 
 E-test is a new approach developed to test antimicrobial susceptibility and it 
should be considered a simple and accurate susceptibility method for the emerging 
need to test most pathogenic organism. 
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OBJECTIVES: 
 
1. To determine of the minimum inhibitory concentration of ciprofloxacin and 
norfloxacin against pathogenic Staphylococcus aureus by using amanual E test. 
2. To compare  between two antimicrobial Susceptibility test disc diffusion and 
manual E test. 
ϯ͘ To determine the minimum inhibitory concentration (MIC) of the isolated 
Staphylococcus aureus with the two antibiotics 
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CHAPTER ONE 
1-LITERATURE REVIEW 
 
ϭ͘ϭ͘^ƚĂƉŚǇůŽĐŽĐĐƵƐĂƵƌĞƵƐ: 
     Staphylococcus aureus is afacultative anaerobic Gram-positive cocci which 
occur singly, in pairs, and irregulular clusters. S. aureus is nonmotile, non-spore 
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forming, catalase and coagulase positive. Typical colonies are yellow to golden 
yellow in color, smooth, entire, slightly raised, and hemolytic on 5% sheep blood 
agar. However, many strains may appear dirty white and nonhemolytic. It also 
gives a positive mannitol fermentation and deoxyribonuclease test.The major 
criterion for identification is the organism’s ability to clot plasma. Each year, some 
500,000 patients in American hospitals contract a staphylococcal infection 
(Bowersox and John,  1999).Staphylococcus. aureus appear as grape-like clusters 
when viewed through a microscope and has large, round, golden-yellow colonies, 
often with hemolysis, when grown on blood agar plates(Ryan and Ray  2004).  
 
ϭ͘ϭ͘ϭ͘ Reproduction: 
    staphylococcus aureus reproduces asexually. It starts this process by 
reproducing its DNA. The membrane stretches out and separates the DNA 
molecules. The cells form a hollow space that eventually divides out into two new 
cells. The new cell wall does not fully separate from the existing cell wall, which is 
why the cells are observed in clusters. This cell will eventually reproduce and cells 
will attach onto it (S. aureus: Reproduction. palexander13.web). 
1.1.2. Pathogenesis: 
      Staphylococcus aureus  is both a commensal, which colonizes the nares, 
axillae, vagina, pharynx, or damaged skin surfaces, and  extremely versatile 
pathogen. It causes super? cial lesions (boils, furonculosis), deep-seated and 
systemic infections (endocarditis, osteomyelitis), and toxemic syndromes (food 
poisoning by releasing enterotoxin into food, toxic shock syndrome by release of 
superantigens into the blood stream, localized and generalized exfoliation by the 
production of exfoliative toxins) ( Lowy , 1998) . 
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.1.1.4.  Adherence to host tissue: 
 Staphylococcus aureus adheres to cells and extra cellular matrix components by 
the joint action of microbial surface component recognizing adhesive matrix 
molecules (MSCRAMM) and secreted expanded repertoire adhesive molecules. 
MSCRAMMs bind molecules such as collagen, fibronectin and fibrinogen, and 
different MSCRAMMs may adhere to the same host-tissue component. Thus, these 
molecules act in initiation of endovascular infections, endocarditis and bone and 
joint infections. By the heterogeneity of MSCRAMMs types, different S. aureus 
strains may be predisposed to causing certain kinds of infections Coagulase is an 
extracellular protein, belonging to the secreted expanded repertoire adhesive 
molecules class, which binds to prothrombin to form a complex called 
staphylothrombin. The protease activity of the thrombin complex is activated, 
resulting in the conversion of fibrinogen to fibrin. Coagulase is produced by almost 
all clinical isolates of  S. aureus  thus it is a traditional marker for identifying S. 
aureus in the clinical microbiology laboratory (Clarke and Foster,  2006).   
1.1.5. Invasion of host tissues: 
The invasion of host tissues by staphylococci apparently involves the production of 
a huge array of extracellular proteins, some of which may occur also as cell-
associated proteins. These proteins are described below with some possible 
explanations for their role in invasive process. 
1.1.5.1. The a , ß , d-toxins: 
The a -toxin is expressed as a monomer that binds to the eukaryotic cell 
membranes, the subunits oligomerize to form heptameric rings with a central pore 
through which cellular contents leak. This toxin also induces the death of innate 
and acquired immunity cells, interferes with the metabolism of arachidonic acid, 
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exocytosis and induces dysfunctions in contractility, leading to bacterial spread and 
alterations of the hemostasis(Bhakdi  and Tranum,  1991) .  
The ß -toxin or sphingomyelinase C is a haemolysin, which targets lipid-rich 
membranes. It causes lysis of erythrocytes and mononuclear cells, and also induces 
a strong inflammatory response. The majority of human isolates of S. aureus do 
not express ß-toxin, but it is frequently found among strains responsible for bovine 
mastitis (Marshall et al.,  2000).  
1.1.5.2. Phospholipase C: 
Staphylococcus. aureus  secretes a phospholipase C, which specifically hydrolysis 
membrane lipid and protein-containing glycosyl phosphatidylinositol (Daugherty  
and Low, 1993) . 
1.1.5.3. Metalloproteases : 
The aureolysine, member of the thermolysines family, is an extracellular and zinc 
dependent metalloprotease. This enzyme destroys host defences 
molecules(Banbula  et al., 1998 ). 
1.1.5.4. Hyaluronidase and hyaluronate lyase: 
These enzymes digest hyaluronic acid, polymer present in the vitreous humour, 
skin, bones and synovial fluid, promoting the infection process by dispersal and 
tissue degradation (Farrell et al., 1995 ) .  
1.1.5.5. Exfolative toxins: 
There are two major biologically and serologically distinct Stahylococcus aureus 
exfolative toxin isoforms, exfolative toxin A and exfolative toxin B, that are 
primarily responsible for the skin manifestations of staphylococcal scalded skin 
syndrome and bullous impetigo. Five per cent of clinical stapylococcus aureus 
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isolates produce either exfoliative toxin A, exfoliative toxin B or both toxins. They 
cleave the stratum  granulosum from the stratum spinosum by targeting 
desmosomes(Amagai  et al.,2002) . 
1.1.5.6. Epidermal cell differentiation inhibitor: 
The epidermal cell differentiation inhibitors which are mono-ADP 
ribosyltransferases belonging to the Rho family, are found in 8% of disease strains 
and in 3.7% of nasal carrier strains under 3 isoforms: epidermal cell differentiation 
inhibitors-A, B and C. Although epidermal cell differentiation inhibitor-A inhibits 
the differentiation of keratinocytes in vitro, the role of epidermal cell 
differentiation inhibitors in human diseases is not established (Yamaguchi et al,
2002) . 
1.1.6. Avoidance of host defenses : 
     Staphylococcus aureus wall consists of two major components, i.e. 
peptidoglycan and lipoteichoic acid, both analogous to the lipopolysaccharide in 
Gram-negative bacteria. They are able to induce the release of cytokines by 
macrophages, the activation of the complement system and the platelets 
aggregation, thus triggering a disseminated intravascular coagulation (Lowy, ) 
. 
 
1.1.6.1. Capsular polysaccharides :  
The majority of clinical isolates of S aureus express a surface polysaccharide of 
either serotype 5 or 8. This has been called a microcapsule because it can be 
visualized only by electron microscopy unlike the true capsules of some bacteria 
which are readily visualized by light microscopy. S. aureus strains isolated from 
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infections express high levels of the polysaccharide but rapidly lose the ability 
when cultured in the laboratory. The function of the capsule in virulence is not 
entirely clear. Although it does impede phagocytosis in the absence of 
complement, it also impedes colonization of damaged heart valves, perhaps by 
masking adhesins(Todar, 2011) 
    
1.1.6.2. Enterotoxins : 
   Staphylococcus  aureus can produce a large diversity of exoproteins belonging to 
the family of superantigens, stimulating polyclonal T-cell proliferation through co-
ligation between major histocompatibility complex (MHC) class II molecules on 
antigen-presenting cells and the variable portion of the T-cell antigen receptor  
with no need for prior antigen-presenting cells processing.. Twenty different 
enterotoxins have been described, among them, staphylococcal toxic shock 
syndrome toxin (TSST-1), staphylococcal enterotoxin A, B, C or enterotoxins 
coded by egc cluster . Beside their superantigenic properties, they are also 
pyrogenic and enteropathogenic for the majority, thus explaining their implication 
in both staphylococcal toxic shock symdrome (TSS) and food poisoning. The 
enterotoxins have also been implicated in a number of autoimmune disorders like 
rheumatic arthritis  and other abnormal immunologic states such as psoriasis, 
atopic dermatitis and Kawasaki syndrome (Cormick etal, 2001). 
 
 
1.1.6.3.Protein A :  
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        Protein A is the most important virulence determinant. It is a surface protein 
ƚŚĂƚĐĂŶďŝŶĚƚŽƚŚĞŚŽƐƚ/Ő'ϱŵŽůĞĐƵůĂƌĂƚĂǁƌŽŶŐŽƌŝĞŶƚĂƟŽŶ͕ǁŚŝĐŚůĞĂĚƐƚŽ
the disfunction of IgG protein and eventually disrupts phagocytosis and 
opsonization (Foster & Hook ͕ϭϵϵϴand Palmqvist et al͕͘ϮϬϬϮͿ͘ 
 
 
1.1.6.4.The fatty acid modifying enzyme and lipases : 
    More than 80%  strains of  Staphylococcus  aureus  express fatty acid modifying 
enzyme which modify antibacterials  lipids and thus may contribute to bacterial 
survival, as in abscesses.  
1.1.6.5. V8 Protease:  
    The V8 protease is an extracellular serine protease witch possesses many 
structural similarities with exfoliative toxin. It cleaves the peptide bonds, 
inactivating in vitro and in vivo the action of antibodies and may protect against 
antimicrobial peptides such as neutrophil defensin proteins and bactericidal platelet 
proteins thus contributing to tissue proteins destruction during the invasion. 
(Prasad and  Leduc, 2004 ) 
 
1.1.6.7.The panton-valentine leukocidin: 
     Is a pore forming toxin which damages human neutrophils, recovered from less 
than 2% of S. aureus strains It has been epidemiologically linked to primary skin 
and soft tissue infections and to deep seated infections such as necrotizing 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
pneumonia and severe recurrent osteomyelitis occurring in young 
immunocompetent patients. The genes coding for leukotoxins LukE-LukD were 
detected in a high prevalence (82%) among blood isolates and 61% among nasal 
isolates. ( Eiff and Friedrich , 2004) 
1.1.6.7. Staphylokinase:  
    The staphylokinase, 136AA protein encoded by a bacteriophage, has two 
important properties. Acting on the immunity, staphylokinase inhibits neutrophils 
bactericides peptides by linking to the a -defensin. On the haemostasis, 
staphylokinase acts as a plasminogen activator which causes dissolution of fibrin 
clots, and lyses fibrin. (Bokarewa and Jin ,2006) 
 
1.1.8.1. Classical diagnosis: 
      Typical gram-positive cocci, in clusters, from a sputum sample Gram stain. 
Depending upon the type of infection present, an appropriate specimen is obtained 
accordingly and sent to the laboratory for definitive identification by using 
biochemical or enzyme-based tests.  Gram stain is first performed to guide the 
way, which should show typical gram-positive  cocci bacteria in clusters. Second, 
the isolate is cultured on mannitol salt agar, which is a selective medium with 7–
9% NaCl that allows S. aureus to grow, producing yellow-colored colonies as a 
result of mannitol fermentation and subsequent drop in the medium's pH. 
Furthermore, for differentiation to the species level, catalase (positive for all 
Staphylococcus species), coagulase (fibrin clot formation, positive for S. aureus), 
DNAse (zone of clearance on nutrient agar), lipase (a yellow color and rancid odor 
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smell), and phosphatase (a pink color) tests are all done. For staphylococcal food 
poisoning, phage typing can be performed to determine   the source of infection. 
 
 
1.1.8.2.Rapid diagnosis and typing: 
     Diagnostic microbiology laboratories and reference laboratories are key for 
identifying outbreaks and new strains of S. aureus. Recent genetic advances have 
enabled reliable and rapid techniques for the identification and characterization of 
clinical isolates of S. aureus in real-time. These tools support infection control 
strategies to limit bacterial spread and ensure the appropriate use of antibiotics. 
These techniques include real-time PCR and quantitative PCR and which 
increasingly being employed in clinical laboratories. (Francois et al., 2008 and 
Mackay, 2007).  
1.1.10.Vaccines:  
 
               A bivalent conjugate vaccine containing capsular S. aureus type 5 and 8 
capsular polysaccharides is undergoing clinical trials (StaphVAX, Nabi, Boca 
Raton, FL). It elicited an antibody response in 75% of hemodialysis patients and 
conferred partial immunity against S. aureus bacteremia for about 40 weeks, with 
an estimated efficacy of 57%( Shinefield .,et al 2002) . Booster doses are safe and 
immunogenic (Fattom .,et al 2004) .  
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 1.1.11. Evolution of Resistance for Staphylococcus aureus to antibacterial 
agent: 
     Following its introduction into clinical practice in the 1940s, penicillin G 
became the treatment of choice for infections caused by S. aureus. However, S. 
aureus resistant to penicillin through the production of a beta-lactamase 
(penicillinase) rapidly emerged (Munch and Boundy , 1962). High levels of 
resistance to penicillin (80-95%) are standard for community strains in almost all 
countries now. Since the 1970s, S. aureus strains resistant to the penicillinase-
resistant penicillins (represented by the original member of the class, methicillin) 
have gradually emerged worldwide ( Ayliffe ,  1997). Until recently, these strains 
have generally been multiresistant, exhibiting resistance to macrolides and 
lincosamides, and usually to tetracyclines and gentamicin. Resistance to 
trimethoprim and sulfonamides is also prevalent in some countries. This type of 
methicillin-resistant S. aureus (MRSA) is now a common cause of nosocomial 
infection in many countries in both the developed and the developing world. The 
rapidity with which MRSA developed in Europe after the introduction of 
methicillin in 1959 and its subsequent spread throughout the world have created 
therapeutic problems for physicians, in part because of the high propensity of 
MRSA to acquire new resistances.  
Methicillin resistance in MRSA isolates is chromosomally mediated and results, at 
least in part, from the presence of an additional and modified penicillin-binding 
protein (PBP-2a), which has reduced affinity for methicillin and other beta-
lactams, and hence retains critical functions necessary for cell survival  (Boyce , 
1998)  .   
Recently different types of MRSA has been described with origins in the 
community in several countries, including Australia, United States, Canada, New 
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Zealand, Saudi Arabia, Finland and Taiwan ( Cookson,   2002)  .Resistance to 
penicillin and methicillin but susceptibility to most or all other drug classes 
characterizes these types of MRSA. 
 
1.2. Antibiotics: 
1.2.1. Definition: 
      The term "antibiotic" was coined by Selman Waksman in 1942 to describe any 
substance produced by a microorganism that is antagonistic to the growth of other 
microorganisms in high dilution (Waksman ,1947).  . This definition excluded 
substances that kill bacteria but are not produced by microorganisms (such as 
gastric juices and hydrogen peroxide). It also excluded synthetic antibacterial 
compounds such as the sulfonamides. Many antibacterial compounds are relatively 
small molecules with a molecular weight of less than 2000 atomic mass units. 
An antibacterial is a compound or substance that kills or slows down the growth of 
bacteria  The term is often used synonymously with the term antibiotic today, 
however, with increased knowledge of the causative agents of various infectious 
diseases, antibiotic(s) has come to denote a broader range of antimicrobial 
compounds, including anti-fungal and other compounds (Dorlands Medical 
Dictionary:antibacterial,2010).  
Antibiotics can further be grouped under the broader heading of chemotherapuetic 
agents, chemical agents used to treat disease. Good chemotherapeutic agents are 
able to kill or inhibit the target pathogen without too much damage to the host 
organism. The basis for this selective toxicity lies in the differences between 
prokaryotic cells of microorganisms and our own eukaryotic cells. The prokaryotic 
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cells of microorganisms differ in a number of ways from our eukaryotic cells, such 
as absence of cell walls, different size of ribosomes, and details of metabolism. 
Thus, the goal of antibiotic therapy is to chose or design drugs that target these 
differences in host and pathogen cells. 
 Bacteria that are prevented from growing will die off after a time or be killed by 
the defence mechanisms of the host. The tetracyclines and the sulphonamides are 
among the bacteriostatic antibiotics. Antibiotics that damage the cell membrane 
cause the cell's Antibiotics are categorized as bactericidal if they kill the 
susceptible bacteria or bacteriostatic if they reversibly inhibit the growth of 
bacteria.. Bacteriostatic drugs are effective because metabolites to leak out, 
eventually killing the organism. These compounds, including penicillin and 
cephalosporin, are therefore classed as bactericidal. Penicillin are the oldest group 
of antibiotics In general the use of bactericidal antibiotics is preferred but many 
factors may dictate the use of a bacteriostatic antibiotic. When a bacteriostatic 
antibiotic is used, the duration of therapy must be sufficient to allow cellular and 
humoral defense mechanisms to eradicate the bacteria. 
 
 
1.2.2. Classification and mode of action: 
     The most common classification has been based on chemical structure and 
proposed mechanism of action. 
1.2.2.1.gents that inhibit synthesis of or activateenyme that disrupt bacterial cell 
wall to cause loss of viability and often, cell lysis, these include penicillin and 
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cephalosporin ,which are structurally similar and dissimilar agent such as 
cycloserine, vancomycin,and bacitracin (Brander et al,.1993). 
1.2.2.2. Agents that act  directly on the cell membrane of the micro organism 
,affecting permeability  and leading to  leakage  of intracellular compound ; these 
include the detergent ,polymyxin and colistmethate and the polyene anti fungal 
agents ,nystatin and amphotericinB,that bind to cell-wall sterols. 
1.2.2.3. Agents that affect the function of bacterial ribosomes to cause areversible 
inhibition of protein synthesis;these bacteriostatic drug  include 
,chlormphenicol,the tetracyclines ,erythromycin, and clindamycine( Alfred et 
al.,1992) 
1.2.2.4. Agentsthat bind to the 30S ribosome sub unit and alter protein synthesis 
,which eventually lead to cell death . these include the amino glycosides. 
1.2.2.5.Agenst that affect nucleic acid metabolism such as the rifamycins  which 
inhibit DNA_dependent RNA polymerase and the quinolones which inhibt DNA 
supercoiling and DNA synthesis (Brander et al .,1993 and Alfred  et al., 1992) . 
1.2.2.6. The antiemetabolites including trimethoprim and the sulfonamides which 
block specific metabolic steps that are essential to microorganisms.  
1.2.2.7.Nucleic acid analogs such as zidovudine ,ganciclovir and vidarabine which 
bind to viral enzymes that are essential for DNA synthesis thus halting viral 
replication (Alfred et al., 1992) . 
1.2.3. Quinolones   
        Quinolones are of important clinical and scientific interest since their 
discovery based on nalidixic acid (1-ethyl-7- methyl-4-oxo-1,8-naphthyridin-3-
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carboxylic acid) in the early 1960s [1(Lesher  et al., 1962)In contrast to most 
antimicrobial agents which were first found as products of bacteria or yeasts, the 
quinolones are synthetic products( Mitscher , 2005  and  Da Silva et al., 2003). 
They are based on two types of ring structures, the quinolone nucleus and the 
naphthyridone nucleus( Ball , 2000) , Compared with older quinolones such as 
norfloxacin (Noroxin) and ciprofloxacin (Cipro), the newer agents have an 
expanded antimicrobial spectrum and new indications , and have enhanced activity 
against Gram-positive bacteria with only a minimal decrease in activity against 
Gram-negative bacteria( Stein, 1996 and  Milkovich and Reitan,  1998)  .  
The fluoroquinolones are bactericidal antibiotics that act by specifically targeting 
DNA gyrase ( Just, 1993) . In contrast to aminoglycosides and beta-lactams, some 
fluoroquinolones are active against dormant and replicating 
bacteria.Fluoroquinolones exhibit a postantibiotic effect following bacterial 
exposure to inhibitory concentrations 
 Six new fluoroquinolones have been introduced in the United States during the 
past five years. Levofloxacin (Levaquin) and sparfloxacin became available in 
1996, and grepafloxacin (Rexar) and trovafloxacin were introduced in 1997. 
Gatifloxacin (Tequin) and moxifloxacin (Avelox) became available in early 2000. 
In December 1999, grepafloxacin was voluntarily withdrawn because of the 
possibility of torsades de pointes occurring with its use. 
Levofloxacin has enhanced activity against strep. pneumoniae, S. aureus and 
Enterococcus species, as well as good activity against Mycoplasma and Chlamydia 
species( Ernst  et al., 1997 and   Appelbaum, 1995) . Sparfloxacin has a further 
expanded spectrum of activity that includes some activity against anaerobes. 
Sparfloxacin has even greater activity against Mycoplasma species .  
 
1.2.3.1. First generation Quinolones: 
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       The first-generation agents include cinoxacin and nalidixic acid, which are the 
oldest and least often used quinolones. Because minimal serum levels are achieved, 
use of these drugs has been restricted to the treatment of uncomplicated urinary 
tract infections. 
Cinoxacin and nalidixic acid require more frequent dosing than the newer 
quinolones, and they are more susceptible to the development of bacterial 
resistance. ( Wolfson and Hooper ,1989 and  Just , 1993)  . 
 
1.2.3.2. Second generation Quinolones: 
 
    The second-generation quinolones have increased Gram-negative activity, as 
well as some  Gram-positive and atypical pathogen coverage. Compared with first-
generation drugs and considered as a group, these agents have broader clinical 
applications in the treatment. Second-generation agents include ciprofloxacin, 
enoxacin, lomefloxacin, norfloxacin and ofloxacin.. 
Ciprofloxacin and ofloxacin are the most widely used second-generation 
quinolones because of their availability in oral and intravenous formulations.  
 
 
1.2.3.3. Third generation Quinolones: 
 
      The third-generation quinolones currently include levofloxacin, gatifloxacin, 
moxifloxacin and sparfloxacin. These agents are separated into a third class 
because of their expanded activity against Gram-positive organisms, particularly 
penicillin-sensitive and penicillin-resistant Staphylococcus  pneumoniae, and 
atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumonia( 
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Stein, 1996 and  Stein  and Havlichek, 1998) .Although the third-generation 
quinolones retain broad Gram-negative coverage, they are less active than 
ciprofloxacin against Pseudomonas species.  
 
 
1.2.3.4.Fourth Generation Quinolones: 
 
      Trovafloxacin is currently the only member of the fourth-generation class, adds 
significant antimicrobial activity against anaerobes while maintaining the Gram-
positive and Gram-negative activity of the third-generation quinolones. It also 
retains activity against Pseudomonas species comparable to that of Ciprofloxacin 
(Brighty and Gootz  1997) . 
1.2.3.5. Bacterial Resistance to Quinolones: 
 
     Gram-positive and Gram-negative bacteria have been reported to be resistant to 
quinolones (Just, 1993 and  Acar et al., 1997) . This resistance appears to be the 
result of one of three mechanisms: alterations in the quinolone enzymatic targets 
(DNA gyrase), decreased outer membrane permeability or the development of 
efflux mechanisms. 
The accumulation of several bacterial mutations (DNA gyrase and bacterial 
permeability) has been associated with the development of very high minimum 
inhibitory concentrations to ciprofloxacin in isolates of Staphylococcus aureus, 
Enterobacteriaceae species and P. aeruginosa (Acar and Goldstein, 1997). 
1.2.4. Norfloxacin: 
     Is a synthetic chemotherapeutic agent( Nelson et al., 2007 and Padei skaia 
,2003) .Norfloxacin is a broad-spectrum antibiotic that is active against both Gram-
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positive and Gram-negative bacteriaGram-positive aerobes include Enterococcus 
faecalis, S. aureus, S. epidermidis, S. saprophyticus, and  Strep. agalactiae. The 
sensitive Gram-negative aerobes include Citrobacter freundii,  Entero. cloacae,  E. 
coli , K. pneumoniae, Neisseria gonorrhoeae, Proteus mirabilis, Proteus vulgaris, 
P . aeruginosa and Serratia marcescens. 
    Norfloxacin is occasionally used to treat common as well as complicated urinary 
tract infections( Rafalsky et al., 2006).The licensed uses for Norfloxacin are quite 
limited as Norfloxacin is to be considered a drug of last resort when all other 
antibiotics have failed. Norfloxacin interacts with a number of other drugs, as well 
as a number of herbal and natural supplements. Such interactions increase the risk 
of anticoagulation and the formation of non-absorbable complexes, as well as 
increasing the risk of toxicity.  
1.2.5. Ciprofloxacin: 
     Ciprofloxacin  is a synthetic chemotherapeutic antibiotic of the fluoroquinolone 
drug class (Nelson et al., 2007 and Kawahara, 1998). Ciprofloxacin was first 
patented in 1983 by Bayer and subsequently approved by the U.S. Food and Drug 
Administration (FDA) in 1987.  
 Ciprofloxacin is a broad-spectrum antibiotic active against both Gram-positive 
and Gram-negative bacteria  which include Enterobacteriaceae , Vibrio, 
Hemophilus influenzae, N. gonorrhoeae, N. menigitidis, Moraxella catarrhalis, 
Brucella ,Mycoplasma Campylobacter Helicobacter pylori ,Mycobacterium 
intracellulare Legionella sp., Pseudomonas aeruginosa and Bacillus anthracis. 
 Ciprofloxacin interacts with other drugs, herbal and natural supplements, and 
thyroid medications(Cooper  et al., 2005). Ciprofloxacin is used to treat a number 
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of infections including: infections of bones and joints, endocarditis, gastroenteritis, 
malignant otitis externa, respiratory tract infections, cellulitis, urinary tract 
infections, prostatitis, anthrax and chancroids  are  among others (Alexander et al., 
2004). Because of its general safety, potency and broad spectrum activity, 
ciprofloxacin was initially reserved as a 'last-resort' drug for use on difficult and 
drug-resistant infections.  
 Resistance to ciprofloxacin and other fluoroquinolones may evolve rapidly, even 
during a course of treatment. Numerous pathogens, including S. aureus, 
enterococci, and Strep. pyogenes now exhibit resistance worldwide ( Jacobs , 
2005).  
1.2.5.1. Mode of action of Norfloxacin and Ciprofloxacin: 
      Norfloxacin and Ciprofloxacin functions by inhibiting DNA gyrase, a type II 
topoisomerase, and topoisomerase IV enzymes necessary to separate bacterial 
DNA, thereby inhibiting cell division( Drlica and Zhao  , 1997 ) . This mechanism 
can also affect mammalian cell replication. In particular, some congeners of this 
drug family ,for example those that contain the C-8 fluorine display high activity 
not only against bacterial topoisomerases, but also against eukaryotic 
topoisomerases and are toxic to cultured mammalian cells and in vivo tumor 
models ( Robinson et al., 1992). Quinolone induced DNA damage was first 
reported in 1986 (Hussy et al., 1986 . 
 
1.2.7. Epsiloter test: 
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     The Epsilometer test ( Etest) is a laboratory test used by microbiologists to 
determine whether or not a specific strain of bacterium or fungus is susceptible to 
the action of a specific antibiotic. This is most commonly used in the setting of 
medicine, where a particular organism has been found to infect a patient, and the 
doctor treating the patient is seeking guidance on what concentration of antibiotic 
is suitable. The principle of the Epsilometer test was first described in 1988 and 
was introduced commercially in 1991 by AB Biodisk. The Etest is basically an 
agar diffusion method.The Etest utilizes a rectangular strip that has been 
impregnated with the drug to be studied. A lawn of bacteria is spread and grown on 
an agar plate, and the Etest strip is laid on top; the drug diffuses out into the agar, 
producing an exponential gradient of the drug to be tested. There is an exponential 
scale printed on the strip. After 24 hours of incubation, an elliptical zone of 
inhibition is produced and the point at which the ellipse meets the strip gives a 
reading for the minimum inhibitory concentration (MIC) of the drug.( Joyce et 
al.,1992). 
 Etest can help to: 
· Determine the MIC of fastidious, slow-growing or nutritionally deficient 
micro-organisms. 
· Confirm/detect a specific resistance phenotype . 
· Detect low levels of resistance. 
· Test an antimicrobial not performed in routine use or a new, recently 
introduced antimicrobial agent. 
· Confirm an equivocal  antibiotics susceptibility tests  result. 
 
1.2.8.The minimum inhibitory concentration 
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    The basic quantitative measures of the in vitro activity of antibiotics are the 
minimum inhibitory concentration (MIC) and the minimum bactericidal 
concentration (MBC).The minimum inhibitory concentration is the lowest 
concentration of an antimicrobial that will inhibit the visible growth of a 
microorganism after overnight incubation. Minimum inhibitory concentrations are 
important in diagnostic laboratories to confirm resistance of microorganisms to an 
antimicrobial agent and also to monitor the activity of new antimicrobial agents 
(Andrews, 2001). AMIC is generally regarded as the most basic laboratory 
measurement of the activity of an antimicrobial agent against an organism 
(Turnidge  et al., 2006). The MBC is the lowest concentration of the antibiotic that 
kills 99.9% of the original inoculums in a given time. MICs can be determined by 
agar or broth dilution methods. There are several commercial methods available, 
including the well established E-test strips.  
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CHAPTER TWO 
Ϯ͘ Materials and Methods 
 
Ϯ͘ϭ͘ Asepsis and sterilization: 
 
 Ϯ͘ϭ͘ϭ͘ ,Žƚ Ăŝƌ ŽǀĞŶ͗ 
        Glassware as Petri dishes, tubes, flasks and paper discs  were sterilized in the 
ŚŽƚĂŝƌŽǀĞŶĂƚϭϴϬ°C for ϯϬŵŝŶƵƚĞƐ͘ 
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   Ϯ͘ϭ͘Ϯ͘ ƵƚŽĐůĂǀŝŶŐ Ăƚ ϭϮϭΣ ͗ 
        For sterilization of media, solutions and screw capped bottles were sterilized 
ďǇĂƵƚŽĐůĂǀŝŶŐĂƚϭϮϭΣĨŽƌϭϱ minutes. 
 
Ϯ͘ϭ͘ϯ͘ ŝƐŝŶĨĞĐƚĂŶƚƐ ĂŶĚ ŝƌƌĂĚŝĂƟŽŶ͗ 
        For septic work and transfers, addition of supplements and  pouring of plates.  
phenolic disinfictants or absolute alcohols was used first for disinfecting floors 
and benches of U.V light ƌŽŽŵĨŽůŽǁĞĚďǇh͘sŝƌƌĂĚŝĂƟŽŶĨŽƌϮϬŵŝŶƵƚĞƐ͘ 
           
Ϯ͘Ϯ͘ Collection of Specimens: 
   Thirty pathogenic Staphylococcus aureus isolates were obtained from wounds, 
skin, and blood and urine samples. Collection depending on site  of infection 
,collection provided by Sohil . 
Ϯ͘ϯ͘ŽŶĮƌŵĂƟŽŶ ƚĞƐƚ͗ 
  Samples identified according to standard morphological and biochemical 
methods. All Staphylococcus aureus were identified primarily by routine 
laboratory procedures by their Gram reaction, morphology, mannitol 
fermentation, catalase, coagulase and DNase production.  
 
Ϯ͘ϯ͘ϭ͘ Gram’s stain 
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Preparation of smears: 
         Small inoculation of the bacteria colony was emulsified in drop of sterile 
normal saline and spread on a clean side. Smears were allowed to dry in air and 
then fixed by gentle heating. 
Method:  Crystal violet stain was added and ĂůŽǁĞĚƚŽƐƚĂŶĚĨŽƌϮͺϯŵŝŶƵƚĞ. 
Excess stain was washed off with a gentle stream of water. 
'ƌĂŵƐŝŽĚŝŶĞǁĂƐĂĚĚĞĚĂŶĚĂůŽǁĞĚƚŽƐƚĂŶĚĨŽƌϯϬƐĞĐŽŶĚƐďefore being rinsed 
off. The stain was washed with Acetone and washed thoroughly in water, then 
stained with the secondary stain, Counterstain with diluted carbol fuchsin, for one 
minute. Washed and drained or blotted to dry. If the bacteria were Gram-
negative, it appeared pink under the microscope. If the cell was Gram-positive, it 
appeared purple under the microscope. 
Ϯ͘ϯ͘Ϯ͘nzyme Tests: 
 
Ϯ͘ϯ͘Ϯ͘ϭ͘ ĂƚĂůĂƐĞ ƚĞƐƚ͗ 
       A ĚƌŽƉŽĨϯйĂƋƵĞŽƵƐƐŽůƵƟŽŶŽĨŚǇĚƌŽŐĞŶƉĞƌŽǆŝĚĞǁĂƐƉůĂĐĞĚŽŶĂĐůĞĂŶ
slide. Small amount of tested organism colony was added to the drop and mixed 
by a wood stick, production of air bubble positive result. 
Staphylococci are catalase positive, what distinguish them from streptococci.  
 
Ϯ͘ϯ͘Ϯ͘Ϯ KǆŝĚĂƐĞ ƚĞƐƚ͗ 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
     The tested organism was grown on nutrient a gar.A piece of filter paper soaked 
ŝŶŽǆŝĚĂƐĞƚĞƐƚƌĞĂŐĞŶƚĂŶĚĚƌŝĞĚĂƚϱϬΣ͕ǁĂƐƉůĂĐĞĚŽŶĂĐůĞĂŶƐŝĚĞ͘dŚĞƚĞƐƚĞĚ
organism was picked with a sterile clean bent glass rod and rubbed on the filter 
paper. A dark purpůĞĐŽůŽƵƌƚŚĂƚĚĞǀĞůŽƉĞĚĂŌĞƌϱ-ϭϬƐĞĐŽŶĚƐŝŶĚŝĐĂƚĞĚƉŽƐŝƟǀĞ
result. 
Ϯ͘ϯ͘Ϯ͘ϯ͘ oagulase test: 
 
 Ϯ͘ϯ͘Ϯ͘ϯ͘ϭ͘ ^ůŝĚĞ ĐŽĂŐƵůĂƐĞ ƚĞƐƚ͗ 
       This test was carried out to detect bound coagulase (clumping factor).Drop of 
physiological saline were placed on each end of a slide. A small proportion of the 
bacterial culture was emulsified in each of the drops to make two thick 
suspensions and mixed gently. Clumping of organism ǁŝƚŚŝŶϭϬƐĞĐŽŶĚƐǁĂƐ
considered as a positive reaction.  
 
 Ϯ͘ϯ͘Ϯ͘ϯ͘Ϯ͘ Tube coagulase test: 
   This test ǁĂƐƉĞƌĨŽƌŵĞĚƚŽĚĞƚĞĐƚĨƌĞĞĐŽĂŐƵůĂƐĞ͘&ƌĞƐŚƉůĂƐŵĂǁĂƐĚŝůƵƚĞĚϭ͗ϭϬ
in physiological saline. Half ml of diluted plasma was placed in a sterile 
ĂŐŐůƵƟŶĂƟŽŶƚĞƐƚƚƵďĞĂŶĚϬϱŵůŽǀĞƌŶŝŐŚƚŐƌŽǁƚŚĐƵůƚƵƌĞŽĨƚŚĞƚĞƐƚĞĚ
organism was added. dŚĞŝŶŽĐƵůĂƚĞĚƚƵďĞǁĂƐƚŚĞŶŝŶĐƵďĂƚĞĚĂƚϯϳΣ͘dŚĞƚƵďĞ
ǁĂƐĞǆĂŵŝŶĞĚĨŽƌĐŽĂŐƵůĂƟŽŶĂŌĞƌϭ͕ϯĂŶĚϮϰŚŽƵƌƐ͘ƉŽƐŝƟǀĞƚĞƐƚǁĂƐ
indicated by coagulation of the tube contents. Positive and negative controls 
were included in the test. 
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Ϯ͘ϯ͘ϯ͘ Culture media: 
Ϯ. ϯ͘ϯ͘ϭ͘Blood agar medium: 
ůŽŽĚƵůƚƵƌĞƵƐƵĂůǇŶĞĞĚƐϮϰ-ϰϴŚŽƵƌƐƚŽŐƌŽǁĂƚϯϱΣ͘S. aureus was produced 
large golden-yellow colonies surrounded by wide zones of hemolysis. 
Ϯ. ϯ͘ϯ͘ϮMannitol Salt Agar medium: 
   Pathogenic Staphylococcus , like S. aureus are mannitol fermenters which 
produce acidic metabolic wastes that turn the originally orange-pink medium to 
bright yellow. 
 
 
 . Ϯ͘ϯ͘ϯ͘ϯ͘ MacConkeys Agar medium: 
  Staphylococcus aureus growing on MacConkey’s Agar ferment lactose, and 
produces  acidic metabolites  that trigger the neutral red pH indicator. This causes 
the bacterial colonies themselves to turn mauve or pink in color 
Ϯ͘ϰ͘ŽŶƚƌŽů ƐƚƌĂŝŶƐ͗ 
    Staphylococcus aureus ATCC 29213 was provided by the Central Public Health 
Laboratory and Staphylococcus aureus ATCC 25923 was obtained from the 
National Center for Medical and Aromatic Plants.  
2.5. Ciprofloxacin & norfloxacin commercial discs: 
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    /ŶƚŚŝƐƐƚƵĚǇǁĞƵƐĞĚϱђŐŝƉƌŽŇŽǆĂĐŝŶĂŶĚϭϬ µg  Norfloxacin sensitivity discs  
to examine the sensitivity of the test organisms by standard discs diffusion 
method. 
2.6. Disk diffusion test: 
     In this method the standardized bacterial isolate was spread on an agar plate and 
then paper disc containing specificconcentrations of antibiotics were placed  on 
the surface and the plates were  incubated at 37oC overnight. If the isolate was 
susceptible to the antibiotic,it did not grow around the disk thus forming a zone of 
inhibition. Strains resistant to an antibiotic grew up to themargin of disk. The 
diameter of zone of inhibition was measured and results read from the Kirby Bauer 
chart assensitive, interimedium. 
 
 
 
 
 
Ϯ͘ϳ. Preparation of manual E-test: 
Ϯ͘ϳ. ϭ͘ Preparation of paper disks: 
    Chinese art paper called Canson was used to prepare discs, because it can 
absorb sufficient volumes of antibiotic solution. Using an ordinary office two-hole 
puncher, paper disks with an ĂƉƉƌŽǆŝŵĂƚĞĚŝĂŵĞƚĞƌŽĨϲ͘ϯŵŵ͘ǁĞƌĞ punched out 
one by one from a sheet of paper, Precautions were taken to avoid overlapping of 
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holes. Since the paper disks have a tendency to curl after punching, they were 
flattened by spreading them in a single -layer on a clean smooth surface then 
pressed by rolling a bottle repeatedly. The disks were placed in a Petri dish, then 
ĂƵƚŽĐůĂǀĞĚĨŽƌϭϱŵŝŶƵƚĞƐĂƚϭϱůďƐƉƌĞƐƐƵƌĞĂŶĚĂůŽǁĞĚƚŽĐŽŽů͘ 
Ϯ͘ϳ. Ϯ͘ WƌĞƉĂƌĂƟŽŶ ŽĨ ƐƚŽĐŬ ƐŽůƵƟŽŶƐ Θ ŝŵƉƌĞŐŶĂƟŽŶ ŽĨ ĚŝƐŬƐ 
Ϯ͘ϳ. Ϯ͘ϭ͘ ^ƚĂŶĚĂƌĚ ĂŶƟďŝŽƟĐ ƉŽǁĚĞƌƐ͗  
      Ciprofloxacin & Norfloxacin( base) powders were obtained from ELIE 
pharmaceuticals with potency 
Ϯ͘ϳ. Ϯ͘Ϯ͘ WƌĞƉĂƌĂƟŽŶ ŽĨ ĂŶƟďŝŽƟĐ ƐŽůƵƟŽŶ͗ 
    The concentration of antibiotic solution expressed in µg ml were based on the 
potency per disk prescribed by WHO and NCCLS (National Committee on Clinical 
Laboratory Standards) of Untied States. It was assumed that a paper disk could 
ĂďƐŽƌďϬ͘ϬϮŵůŽĨĂƐŽůƵƟŽŶƐ͘ /ŶƚŚĞƉƌĞƉĂƌĂƟŽŶŽĨĂŵƉŝĐŝůŝŶǁŝƚŚĂƉŽƚĞŶĐǇŽĨϭϬ
mcg, the antibiotic solution contained ϱϬϬŵĐŐŽĨĂŵƉŝĐŝůŝŶƉĞƌŵůŽĨƐŽůƵƟŽŶ͘
The following formula was used in determining the amount of antibiotic powder 
to be used: 
 Vol. (ml) x desired conc. (ug/ml) Weight (mg) = Potency (ug/mg) 
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Example: 
ϱŵůǆϱϬϬƵŐͬŵůtĞŝŐŚƚ;ŵŐͿсϴϲϬƵŐͬŵůсϮ͘ϵϭŵŐ 
 
Ϯ͘ϳ. ϯ͘ Preparation of serial dilutions:     
      Nine  different concentrations were made  from the two antibiotics by two-
ĨŽůĚĚŝůƵƟŽŶŵĞƚŚŽĚƚŽĐŽŶƚĂŝŶĨŽƌŝƉƌŽŇŽǆĂĐŝŶϭϬ͕ϱ͕Ϯ͘ϱ͕ϭ͘Ϯϱ͕͘ϲϮ͕͘ϯϭ͕͘ϭϱ͕͘Ϭϳ
͕͘Ϭϯµg/ml, and for EŽƌŇŽǆĂĐŝŶϮϬ͕ϭϬ͕ϱ͕Ϯ͘ϱ͕ϭ͘Ϯϱ͕ϲϮ͕͘ϯϭ͕ϭϱ͕͘Ϭϳ µg/ml ͘ϴµg/ml 
(were Prepared from the stock of each antibiotic solutions). The first tube in each 
raw was  from the appropriate stock solution already made. Other tubes 
ĐŽŶƚĂŝŶŝŶŐϰŵůǁĂƚĞƌĂƐĂĚŝůƵĞŶƚ͘Using a fresh pipette ϰ ml of stock solution 
ǁĞƌĞĂĚĚĞĚĨƌŽŵĮƌƐƚƚƵďĞƚŽƚŚĞƐĞĐŽŶĚƚƵďĞ͕ŵŝǆĞĚϰŵůǁĞƌĞƚƌĂŶƐĨĞƌƌĞĚƚŽ
the next tube until the last tube . 
Ϯ͘ϳ. ϰ͘ Impregnation of disk: 
     Blank disks were soaked in known concentrations of antibiotics and then 
allowed to dry for ϯ hours,  The impregnated disks were then transferred to 
sterile Petri dishes and labeled  with their defined concentrations.  
Ϯ͘ϳ. ϱ͘ Drying and storage: 
    Disks was partially covered   were allowed to dry in a clean incubator at ϯϱΣĨŽƌ
Ϯ-ϯŚŽƵƌƐ͘ 
Ϯ͘ϳ.ϲ͘ WƌĞƉĂƌĂƟŽŶ of inoculua: 
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     The direct colony suspension method was used to make a suspension of the 
organism in saline to the density of a McFarland? s tube Ϭ͘ϱƚƵƌďŝĚŝƚǇƐƚĂŶĚĂƌĚ. 
Ϯ͘ϳ͘ϳ͘ Antimicrobial susceptibility test: 
    Antimicrobial susceptibility test of the isolated organisms was done by disc 
diffusion method using the Kirby-Bauer technique (Bauer et al., ϭϵϲϲͿĂŶĚĂƐƉĞƌ
recommended by of NCCLS  (NCCLS, ϮϬϭϭ)  . The adjusted inoculua suspensions 
were  used ǁŝƚŚŝŶϭϱŵŝŶŽĨƉƌĞƉĂƌĂƟŽŶ͘A sterile cotton swab was dipped into 
each suspension and the excess fluid was removed by turning the swab against 
the inside of the container. It is important to remove excess fluid from the swab 
to avoid over-inoculation of plates. The inoculum was spread evenly over the 
entire surface of the plate by swabbing in three directions. Impregnated discs 
were applied with sterile  avacutainer needle and put in single strip from 
maximum to minimum concentration ;&ŝŐ͘ϭͿ͘ The antibiotics diffused out into the 
agar, producing an exponential gradient of the antibiotics to be tested. There was 
ĂŶĞǆƉŽŶĞŶƟĂůƐĐĂůĞƉƌŝŶƚĞĚŽŶƚŚĞĚŝƐŬƐƐƚƌŝƉ͘ŌĞƌϭ ϲ-ϭϴ hours of incubation, 
an elliptical zone of inhibition was produced ,then the minimum inhibitory 
concentration (MIC) of the antibiotics was reading .  
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dĂďůĞ;ϮͿ: Reference strains results in Disk diffusion technique: 
organism 
Zone inhibition diameter/mm 
Ciprofloxacin Nofloxacin 
Staphylococccus aureus 
dϮϱϵϮϯ 
;ϮϮ-ϯϬͿ ;ϭϳ-ϮϴͿ 
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dĂďůĞ;ϯͿ Reference strains results in E-test technique: 
organism 
MIC mcg/ml 
Ciprofloxacin Nofloxacin 
Staphylococccus aureus 
d ϮϵϮϭϯ 
Ϭ͘Ϯϱ 
;Ϭ͘ϭϮ-Ϭ͘ϱͿ 
Ϭ͘ϱ 
;Ϭ͘ϱ-ϮͿ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
  
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
&ŝŐƵƌĞϭ͗ The manual E-test the discs, making single strips from maximum to 
minimum concentration. 
 
 
 
 
 
 
 
CHAPTER THREE 
3. RESULT 
 
    In the present study  ϯϬĐůŝŶŝĐĂůŝƐŽůĂƚĞƐ  of Staphylococcus aureus  were tested 
for their  senstivity  by both disk diffusion agar method and manual  E-test 
method against two guinolones (Ciprofloxacin and Norfloxacin) .Also in this study 
we conducted a  comparison between manual E-test and  disk diffusion Agar. 
   There were  differences  in  susceptibility tests  by the disk diffusion  and manual 
E-test methods. dŚĞĚŝƐŬĚŝīƵƐŝŽŶŵĞƚŚŽĚƐŚŽǁĞĚƐĞŶƐŝƟǀŝƟĞƐŽĨϳϯ͘ϯйĂŶĚ
ϲϯ͘ϯйĨŽƌŝƉƌŽŇŽǆĂĐŝŶĂŶĚEŽƌŇŽǆĂĐŝŶƌĞƐƉĞĐƟǀĞůǇ;dĂďůĞϰͿ͕ǁŝƚŚŵĂŶƵĂů-test 
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ƚŚĞƐĞŶƐŝƟǀŝƚǇǁĂƐϴϬйĂŶĚϴϲйĨŽƌŝƉƌŽŇŽǆĂĐŝŶĂŶĚEŽƌĨloxacin   
ƌĞƐƉĞĐƟǀĞůǇ;dĂďůĞϱĂŶĚ&ŝŐϮ͕ϯͿ͘ 
ƚ^ƌĂŝŶϴ͕ϭϭĂŶĚϮϲĂƉƉĞĂƌĞĚǁĞƌĞƌĞƐŝƐƚĂŶƚĨŽƌďŽƚŚĂŶƟďŝŽƟĐƐ;&ŝŐϴĂŶĚϵ ).  
StrainƐϭ͕ϲ͕ϭϳĂŶĚϮϬǁĞƌĞŵŽƌĞƐĞŶƐŝƟǀŝƚĞ ƚŽŝƉƌŽŇŽǆĂĐŝŶ;D/сфϬ͕ϬϯͿ;&ŝŐϭϬͿ
͘tŚĞƌĞĂƐƐƚƌĂŝŶƐϲĂŶĚϮϳǁĞƌĞŵŽƌĞƐĞŶƐŝƟǀŝƚĞƚŽEŽƌŇŽǆĂĐŝŶ;D/схϬ͘ϬϳͿ (Fig 
ϭϬͿ͘ 
 One strain showed intermediate sensitivity to Norfloxacin and three strains  to 
ŝƉƌŽŇŽǆĂĐŝŶ;dĂďůĞϱͿ͘ 
  
  
 
 
 
 
 
 
  dĂďůĞ;ϰͿ͗^ĞŶƐŝƟǀŝƚǇ of S.aureus strains to Ciprofloxacin and Norfloxacin by the 
disc diffusion method: 
 
interpretation* Ciprofloxacin Norfloxacin Total 
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Sensitive ϮϮ ϳϯ͘ϯй ϭϵ ϲϯ͘ϯй ϰϭ 
Intermediate Ϭ _ Ϯ ϲ͘ϳй ϭϳ 
Resistant  Ϭ _ Ϯ  ϲ͘ϳй Ϯ 
Total ϯϬ ϭϬϬй ϯϬ ϭϬϬй ϲϬ 
 
 
 
· For ciprofloxacin zone diameter/mm = 21 (sensitive), 16-20(intermediate), and= 15 (resistant) 
(NCCLs). 
· For norfloxacin  zone diameter/mm = 17 (sensitive), 13-16(intermediate), and= 12 (resistant) 
(NCCLs).  
 
dĂďůĞ;ϱ): Sensitivity  of S.aureus strains to Ciprofloxacin and Norfloxacin by the 
manual E test: 
ϭͺMIC= ϭµg/ml (sensitive), Ϯµg/ml (intermediate), and= ϰµg/ml (resistant). 
Ϯ-MIC чϰђŐ/ml ;ƐĞŶƐŝƟǀĞͿ͕ϴµg/ml (intermediate), and= ϭϲµg/ml (resistant). 
 
 
Interpretation Ciprofloxacin Norfloxacin Total 
Sensitive Ϯϰ ϴϬ% Ϯϲ ϴϲ͘ϳ% ϱϬ 
Intermediate ϯ ϭϬ% ϭ ϯ͘ϯ% ϰ 
Resistant ϯ ϭϬ% ϯ ϭϬ% ϲ 
Total ϯϬ ϭϬϬй ϯϬ ϭϬϬй ϲϬ 
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 dĂďůĞ;ϲ): MIC values of  Norfloxacin  for  S.aureus strains:  
 
 
dĂďůĞ;ϳ): MIC values of  Ciprofloxacin  for S.aureus  strains : 
 
 
 
dĂďůĞ;ϴ): Significant difference in MIC and zone diameter values of the S.aureus 
strains between the two antibiotics: 
 
MIC δͲǤͲ͹ ͲǤͲ͹ ͲǤͳͷ ͲǤ͵ͳ ͲǤ͸ʹ  ͳǤʹͷ Ǥʹͷ ͷ ͳͲ 
 ʹ
Ͳ εʹͲ Total 
Norfloxacin Ϯ ϴ ϴ ϱ Ϭ Ϭ ϯ ϭ Ϭ 
 
Ϭ 
ϯ ϯϬ 
MIC 
δͲǤͲ
 ͵
ͲǤͲ
 ͵
ͲǤͲ
͹ 
ͲǤͳ
ͷ 
ͲǤ͵
ͳ 
ͲǤ͸
 ʹ
ͳǤʹ
ͷ 
Ǥʹ
ͷ 
ͷ 
 
ͳ
Ͳ 
 
εͳ
Ͳ 
Tota
l 
ciprofloxaci
n 
ϰ ϳ ϵ Ϯ ϭ ϭ Ϭ ϯ Ϭ 
 
Ϭ ϯ ϯϬ 
 
Paired Differences t Df 
Sig. (2-
tailed) 
  
Mean 
Std. 
Deviation 
Std. Error 
Mean 
95% 
Confidence 
Interval of the 
vac2-1 - 
vac2-2   
vac1-1 - vac1-2 
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Note 
 Vac1-1:ciprofioxacin by E test 
 vac1-2:ciprofloxacin by zone diameter 
 vac2-1: norfloxacin by Etest 
 vac2-2:norfloxacin by zone diameter 
 
 
 
Table (ϵ): Summarized E test and zone diameter values of  S.aureus strains against 
the tow antibiotics: 
 
 
Difference 
 
-21.54367 10.61632 1.93827 -25.50787 -17.57947 
-
11.1
15 
vac
2-1 
- 
vac
2-2 
.000 
 
vac1-1 - vac1-2 
 
-19.26833 10.94188 1.99771 -23.35410 -15.18257 
-
9.64
5 
29 .000 
vac2-1 - vac2-2 
Mean N Std. Deviation 
Std. Error 
Mean 
 
.3230 30 .74740 .13646 Vac1-1 
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Note: 
 Vac1-1:ciprofioxacin by E test 
 vac1-2:ciprofloxacin by zone diameter 
 vac2-1: norfloxacin by Etest 
 vac2-2:norfloxacin by zone diameter 
 
 
 
 
 
 
   
 
 
 
 
21.8667 30 10.42455 1.90325 vac1-2 
.5317 30 1.11385 .20336 vac2-1 
19.8000 30 10.57127 1.93004 vac2-2 
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&ŝŐƵƌĞϮ:  E-test interpretation values for the Norfloxacin. 
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&ŝŐƵƌĞϯ:  E-test interpretation& values for the Ciprofloxacin. 
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&ŝŐƵƌĞϰ: Frequency distribution of MIC values against Ciprofloxacin. 
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 &ŝŐƵƌĞϱ͗ Frequency distribution of MIC values against Norfloxacin. 
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&ŝŐƵƌĞϲ͗Frequency distribution of Zone diameter against Ciprofloxacin 
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 &ŝŐƵƌĞϳ͗Frequency distribution of zone diameter against Norfloxacin 
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&ŝŐƵƌĞϴ͗ ƚ^ƌĂŝŶEŽ;ϴͿĂƉƉĞĂƌƐ as amutant strain for both antibiotics 
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&ŝŐƵƌĞϵ: Strain No (ϭϭ͕Ϯϲ) showed resistant to both antibiotics. 
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Figure ϭϬ: Strains No( ϲͿ show more sensitivity ƚŽŝƉƌŽŇŽǆĂĐŝŶ;D/сфϬ͕ϬϯͿĂŶĚ
show more sensitivity ƚŽEŽƌŇŽǆĂĐŝŶ;D/схϬ͘ϬϳͿ 
 
 
 
 
 
 
CHAPTER FOUR 
4. DISCUSSION 
 
    The aim of this study was to determine the MICs of Ciprofloxacin and 
Norfloxacin against pathogenic Staphylococcus aureus and to compare between 
the disc diffusion and E-test methods.  
The present study an  increase in resistance to two the antibiotics in the disk 
diffusion  and manual E-test methods. In disk diffusion method showed 
sensitivities of 73.3% and 63.3%  were demonstrated  for Ciprofloxacin and 
Norfloxacin respectively( Table.3) ,where as with  manual E-test the sensitivities 
were  80% and 86% for Ciprofloxacin and Norfloxacin   respectively(Table 4 and 
Fig 4,5) .Th e above result substantiate the work of Nccls,(1988) in that 
Ciprofloxacin-resistant S. aureus isolates, MICs were considered to be higher  than 
2,ug/ml), and for Ciprofloxacin-susceptible staphylococcus  aureus, MICs were 
considered to be less than 1ug/ml, our results agree with this results ( Table 6).  
With Bauernfeind,(1983) in vitro antibacterial  activity  to Norfloxacin and 
Nalidixic acid reported that the MICs for staphylococcus ranged from .008_2.0 
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mgL. our study  agree  with  this study  in that the  MIC range from 0.07_2.5,ug/ml 
(Table 5).                                            
 Our result is an  agreement with Yah et al.,(2004), Adel et al.,(2005 ) and 
Ravisekhar et al.,(2006)  since they verified  that the isolates  were    sensitive to 
the quinolones( Ciprofloxacin and Ofloxacin) with MICs range  0.002-32µ g/ml  
thier Sensitivity 81%,  Intermediate 10%,  Resistance 6%  (Table 4). 
  Our result also agreement with  lecturer et al.,(2005) since  he  found that 
staphylococcus aureus was most sensitive to   Norfloxacin (65.5%).                         
Islam et al ., (2008)  reported  that  all  MRSA isolates in the study appeared 
sensitive to  Vancomycin, Ciprofloxacin, Erythromycin, Fusidic acid and 
Rifampicin, this result did not agree with our result.     
The present  study  agree with previous finding in that there are increase in 
resistant to both antibiotics .  
 This resistance appears to be the result of one of three mechanisms: alterations in 
the quinolone enzymatic targets (DNA gyrase), decreased outer membrane 
permeability or the development of efflux mechanisms. 
The accumulation of several bacterial mutations (DNA gyrase and bacterial 
permeability) has been associated with the development of very high minimum 
inhibitory concentrations to quinolones. 
Resistance of pathogens to these available, cheap, older and commonly used drugs 
would definitely result in high cost of treatment, longer hospital stay and 
therapeutic failure, which might lead to life-threatening diseases and more deaths.                                  
Staphylococcus species have traditionally been one of the most significant Gram-
positive pathogens in major bacterial infections. However, despite their improved 
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activities, newer drug still carry the risk of resistance selection, particularly 
Staphylococcus pathogens that have already intermediate resistance to 
antimicrobials. This is a clinical problem, especially with Methicillin resistant 
Staphylococcus aureus (MRSA) isolates which are widely resistant to quinolones . 
                                         
 
 
 
                                                                                                                    
 
 
CONCLUSION 
 
    This study was attempted to evaluate the resistance of staphylococcus aureus 
against   quinolone ciprofloxacin and norfloxacin, and their MIC values using 
manual E-test.  
   The use of the E-test is easier and more practical than the use of the other 
methods for most laboratories. However, the higher cost of the E-Test method 
would likely discourage most laboratories from selecting it over disk diffusion for 
routine antimicrobial susceptibility testing of pathogenic bacteria. The results 
showed that E-test strip method is a reliable, rapid, easy but slightly expensive in 
susceptibility testing technique. It combines the activity of both diffusion and MIC 
dilution methods; this combination increases the sensitivity of E-test, and the 
results showed that manual E-test strip method is more reproducible, reliable, easy 
and cheaper than the E-test strip. By E-test  the  doctor  treating the patient is 
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seeking guidance on what concentration of antibiotic is suitable. E-test can help in 
the  Determination the MIC of fastidious, slow-growing or nutritionally deficient 
micro-organisms,detect a specific resistance phenotype and detect low levels of 
resistance. 
 
  
 
 
 
 
 
 
 
RECOMMENDATION 
 
    The E-test should be considered a simple and accurate susceptibility method for 
the emerging need to test Staphylococcus aureus and other pathogenic bacteria.  
The relatively higher cost of the E-test procedure precludes us from recommending 
it for routine use so that we recommended to decreasing the cost from using it as a 
routine test in laboratories for antimicrobial susceptibility testing.  
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  The use of E-test in research and hospitals in Sudan is recommended because it 
is a quantitative technique for determining the antimicrobial susceptibility of 
Gram- negative and Gram -positive aerobic bacteria. The E test is widely used 
because of its simplicity in comparison with dilution methods. 
    We recommended to avoiding the misuse of antibiotics which lead more 
resistance to these antibiotics in future and will lead therapeutic failure.  
The use of E-test in research and hospitals in Sudan is recommended because it is a 
quantitative technique for determining the antimicrobial susceptibility of Gram- 
negative and Gram -positive aerobic bacteria.  
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